...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Evaluation of the Risk for Tay-Sachs Disease in Individuals of French Canadian Ancestry Living in New England
【24h】

Evaluation of the Risk for Tay-Sachs Disease in Individuals of French Canadian Ancestry Living in New England

机译:对居住在新英格兰的加拿大法裔祖先的人进行泰氏病风险的评估

获取原文

摘要

Background: The assessment of risk for Tay-Sachs disease (TSD) in individuals of French Canadian background living in New England is an important health issue. In preliminary studies of the enzyme-defined carrier frequency for TSD among Franco-Americans in New England, we found frequencies (1:53) higher than predicted from the incidence of infantile TSD in this region. We have now further evaluated the risk for TSD in the Franco-American population of New England.Methods: Using a fluorescence-based assay for β-hexosaminidase activity, we determined the carrier frequencies for TSD in 2783 Franco-Americans. DNA analysis was used to identify mutations causing enzyme deficiency in TSD carriers.Results: We determined the enzyme-defined carrier frequency for TSD as 1:65 (95% confidence interval 1:49 to 1:90). DNA-based analysis of 24 of the enzyme-defined carriers revealed 21 with sequence changes: 9 disease-causing, 4 benign, and 8 of unknown significance. Six of the unknowns were identified as c.748GA p.G250S, a mutation we show by expression analysis to behave similarly to the previously described c.805GA p.G269S adult-onset TSD mutation. This putative adult-onset TSD c.748GA p.G250S mutation has a population frequency similar to the common 7.6 kb deletion mutation that occurs in persons of French Canadian ancestry.Conclusions: We estimate the frequency of deleterious TSD alleles in Franco-Americans to be 1:73 (95% confidence interval 1:55 to 1:107). These data provide a more complete data base from which to formulate policy recommendations regarding TSD heterozygosity screening in individuals of French Canadian background.
机译:背景:对居住在新英格兰的具有加拿大裔背景的个人进行的泰-萨克斯病(TSD)风险评估是一个重要的健康问题。在对新英格兰法裔美国人中TSD酶定义的载频的初步研究中,我们发现该区域的频率(1:53)高于该地区婴儿TSD发生率所预测的频率。现在,我们进一步评估了新英格兰法裔美国人中TSD的风险。方法:使用基于荧光的β-己糖胺酶活性分析,我们确定了2783名法裔美国人TSD的携带者频率。 DNA分析用于鉴定导致TSD载体中酶缺乏的突变。结果:我们确定TSD的酶定义的载体频率为1:65(95%置信区间为1:49至1:90)。基于DNA的24种酶定义载体的分析显示21种具有序列变化:9种致病,4种良性和8种未知。六个未知物被鉴定为c.748G> A p.G250S,我们通过表达分析表明该突变与先前描述的c.805G> A p.G269S成年TSD突变行为相似。该推定的成年性TSD c.748G> A p.G250S突变的种群频率与加拿大加拿大血统的人中常见的7.6 kb缺失突变相似。结论:我们估算了法裔美国人中有害TSD等位基因的频率为1:73(95%置信区间1:55至1:107)。这些数据提供了更完整的数据库,可用于制定有关加拿大法裔背景的TSD杂合性筛查的政策建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号